B
Basira Najafzadeh
Researcher at University of Tabriz
Publications - 9
Citations - 125
Basira Najafzadeh is an academic researcher from University of Tabriz. The author has contributed to research in topics: Homeobox protein NANOG & SOX2. The author has an hindex of 3, co-authored 4 publications receiving 39 citations. Previous affiliations of Basira Najafzadeh include Tabriz University of Medical Sciences.
Papers
More filters
Journal ArticleDOI
The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV.
Nima Hemmat,Zahra Asadzadeh,Noora Karim Ahangar,Hajar Alemohammad,Basira Najafzadeh,Afshin Derakhshani,Amir Baghbanzadeh,Hossein Bannazadeh Baghi,Darya Javadrashid,Souzan Najafi,Meriadeg Ar Gouilh,Behzad Baradaran +11 more
TL;DR: In this paper, the authors summarize alterations of cellular signaling pathways that are associated with coronavirus infection, particularly SARS-CoV and MERSCoV, and tabulate the therapeutic agents that are currently approved for treating other human diseases.
Journal ArticleDOI
The oncogenic potential of NANOG: An important cancer induction mediator.
Basira Najafzadeh,Zahra Asadzadeh,rohollah motafakker azad,Ahad Mokhtarzadeh,Amir Baghbanzadeh,Hajar Alemohammad,Mahdi Abdoli Shadbad,Parisa Vasefifar,Souzan Najafi,Behzad Baradaran +9 more
TL;DR: It is intended to demonstrate that targeting NANOG can dimmish the CSCs, sensitize the tumor to chemotherapy, and eradicate the cancer cells.
Journal ArticleDOI
Nanog, as a key cancer stem cell marker in tumor progression.
Parisa Vasefifar,Rohollah Motafakker Azad,Leili Aghebati Maleki,Souzan Najafi,Farid Ghrobaninezhad,Basira Najafzadeh,Hajar Alemohammad,Mohammad Amin Amini,Amir Baghbanzadeh,Behzad Baradaran +9 more
TL;DR: In this paper , a review aimed to focus on the function of Nanog in multiple cancers based on recent studies surveying the suitable approaches to target Nanog and inhibit CSCs residing in tumors to gain favorable results from cancer treatments.
Journal ArticleDOI
Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction.
Hajar Alemohammad,Zahra Asadzadeh,rohollah motafakker azad,Nima Hemmat,Basira Najafzadeh,Parisa Vasefifar,Souzan Najafi,Behzad Baradaran +7 more
TL;DR: This review will investigate the function of NANOG in CSCs and the molecular mechanism of its regulation by signaling pathways and miRNAs, which is a promising treatment strategy for cancer treatment.
Journal ArticleDOI
Silencing of Nanog as a promising therapeutic approach against liver cancer; how this silencing could increase the sensitivity to Cisplatin.
Hajar Alemohammad,Rouhollah Motafakkerazad,Zahra Asadzadeh,N. Farsad,Nima Hemmat,Basira Najafzadeh,Parisa Vasefifar,Behzad Baradaran +7 more
TL;DR: In this paper , the authors evaluated the impact of combination therapy of Nanog siRNA/cisplatin on the sensitivity of liver cancer cells to this drug and found that Nanog inhibition in combination with cisplatin is a potential therapeutic strategy for developing new therapeutic approaches for liver cancer.